Dr Paul Kasian | Non-Executive Director

Dr. Kasian brings to the Board a combination of expertise in strategic business leadership and biotech investment giving him a deep understanding on key value drivers for companies in generating shareholder value. He is an experienced executive director with demonstrated domestic and international success in both biotechnology and funds management, encompassing senior leadership, investment and risk roles.

Dr. Kasian currently serves as a Non-Executive Director of Genetic Technologies Group (ASX;GTG), IODM Limited (ASX:IOD) and Blockchain Global Limited. Previously he has held senior leadership positions in a number of investment groups including, inter alia, Chief Investment Officer at HSBC Asset Management and Project Leader ICI Australia Biotechnology Unit.